168 related articles for article (PubMed ID: 38588015)
1. GHITM regulates malignant phenotype and sensitivity to PD-1 blockade of renal cancer cells via Notch signalling.
Huang S; Liu J; Hu J; Hou Y; Hu M; Zhang B; Luo H; Fu S; Chen Y; Liu X; Chen Z; Wang L
J Cell Mol Med; 2024 Apr; 28(8):e18290. PubMed ID: 38588015
[TBL] [Abstract][Full Text] [Related]
2. ORM1 promotes tumor progression of kidney renal clear cell carcinoma (KIRC) through CALR-mediated apoptosis.
Yu G; Gao J; Hu W; Hu D; Wang W; Yang S; Gao J
Sci Rep; 2023 Sep; 13(1):15687. PubMed ID: 37735575
[TBL] [Abstract][Full Text] [Related]
3. miR-138-5p inhibits proliferation and invasion in kidney renal clear cell carcinoma by targeting SINA3 and regulation of the Notch signaling pathway.
Liu Y; Qu HC
J Clin Lab Anal; 2021 Nov; 35(11):e23766. PubMed ID: 34586647
[TBL] [Abstract][Full Text] [Related]
4. OCLN as a novel biomarker for prognosis and immune infiltrates in kidney renal clear cell carcinoma: an integrative computational and experimental characterization.
Jia Z; Kong Y; Wang C; Fu Z; Tian Z; Sun Y; Lin Y; Huang Y
Front Immunol; 2023; 14():1224904. PubMed ID: 37809090
[TBL] [Abstract][Full Text] [Related]
5. Identification of berberine as a potential therapeutic strategy for kidney clear cell carcinoma and COVID-19 based on analysis of large-scale datasets.
Zheng Z; Li X; Nie K; Wang X; Liang W; Yang F; Zheng K; Zheng Y
Front Immunol; 2023; 14():1038651. PubMed ID: 37033923
[TBL] [Abstract][Full Text] [Related]
6. Multi-omics pan-cancer study of cuproptosis core gene
Xu J; Hu Z; Cao H; Zhang H; Luo P; Zhang J; Wang X; Cheng Q; Li J
Front Immunol; 2022; 13():981764. PubMed ID: 36605188
[TBL] [Abstract][Full Text] [Related]
7. Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma.
Chen CC; Chu PY; Lin HY
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240154
[TBL] [Abstract][Full Text] [Related]
8. [Implications of TCGA Network Data on 2nd Generation Immunotherapy Concepts Based on PD-L1 and PD-1 Target Structures].
Peters I; Tezval H; Kramer MW; Wolters M; Grünwald V; Kuczyk MA; Serth J
Aktuelle Urol; 2015 Nov; 46(6):481-5. PubMed ID: 26560846
[TBL] [Abstract][Full Text] [Related]
9. Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma.
Zhang G; Chen X; Fang J; Tai P; Chen A; Cao K
Front Immunol; 2022; 13():954440. PubMed ID: 36059510
[TBL] [Abstract][Full Text] [Related]
10. Integrative analysis of LAG3 immune signature and identification of a LAG3-related genes prognostic signature in kidney renal clear cell carcinoma.
Li J; Liu C; Su H; Dong H; Wang Z; Wang Y; Zhao P; Zhang C; Zhao Y; Ma X
Aging (Albany NY); 2024 Jan; 16(3):2161-2180. PubMed ID: 38277212
[TBL] [Abstract][Full Text] [Related]
11.
Situ Y; Zhang J; Liao W; Liang Q; Lu L; Xu Q; Chen J; Lu X; Cui Y; Shao Z; Deng L
Front Biosci (Landmark Ed); 2023 Sep; 28(9):196. PubMed ID: 37796681
[TBL] [Abstract][Full Text] [Related]
12. NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling.
Yin L; Li W; Wang G; Shi H; Wang K; Yang H; Peng B
J Exp Clin Cancer Res; 2019 Aug; 38(1):343. PubMed ID: 31391070
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of DBT suppresses the aggressiveness of renal clear cell carcinoma and correlates with immune infiltration.
Zhang C; Huang G; Yang J; Jiang Y; Huang R; Ye Z; Huang Y; Hu H; Xi X
Front Immunol; 2023; 14():1197011. PubMed ID: 37383233
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of the relation to tumor immune microenvironment and predicted value of Stonin1 gene for immune checkpoint blockage and targeted treatment in kidney renal clear cell carcinoma.
Zheng A; Bai J; Ha Y; Yu Y; Fan Y; Liang M; Lu Y; Shen Z; Luo B; Jie W
BMC Cancer; 2023 Feb; 23(1):135. PubMed ID: 36759775
[TBL] [Abstract][Full Text] [Related]
15. LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription.
Xie X; Lin J; Fan X; Zhong Y; Chen Y; Liu K; Ren Y; Chen X; Lai D; Li X; Li Z; Tang A
Cell Death Dis; 2021 Feb; 12(2):201. PubMed ID: 33608495
[TBL] [Abstract][Full Text] [Related]
16. Cuproptosis-Related 4-Gene Risk Model for Predicting Immunotherapy Drug Response and Prognosis of Kidney Renal Clear Cell Carcinoma.
Guo JS; Ding H; Wu PY; Xin ZY; Li JX; Jo HS; Ma ZH
Chin Med Sci J; 2023 Sep; 38(3):191-205. PubMed ID: 37503721
[TBL] [Abstract][Full Text] [Related]
17. ApoM suppresses kidney renal clear cell carcinoma growth and metastasis via the Hippo-YAP signaling pathway.
Xu T; Wei D; Yang Z; Xie S; Yan Z; Chen C; Hu W; Shi Z; Zhao Y; Cui M; Xu Z; Wang J
Arch Biochem Biophys; 2023 Jul; 743():109642. PubMed ID: 37211224
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma.
Cui Y; Yan M; Zhang C; Xue J; Zhang Q; Ma S; Guan F; Cao W
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1993-2006. PubMed ID: 32444962
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
[TBL] [Abstract][Full Text] [Related]
20. LINC00997, a novel long noncoding RNA, contributes to metastasis via regulation of S100A11 in kidney renal clear cell carcinoma.
Chang Y; Li N; Yuan W; Wang G; Wen J
Int J Biochem Cell Biol; 2019 Nov; 116():105590. PubMed ID: 31442606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]